By activating GLP-1 receptors, these drugs help control appetite, food intake, and blood sugar levels, making them useful for diabetes
In addition, it is the leading cause of hospitalization in the group aged 65 years and older.1 In the United States, HF has an estimated prevalence of 6 million people (1.8% of the population).2 It is associated with high mortality (50%-60% at 5 years) and morbidity rates, and a particularly significant reduction in quality of life.3 Currently, the most widely used criterion to classify HF patients is left ventricular ejection fraction (EF)
Oral forms are safer
Separating doses throughout the day sacrifices this synergistic effect
1, 2 Diet and life-style modification represent the first-line treatment in the management of obesity, but as these often fail to provide sustainable weight loss, pharmaceutical intervention may be necessary for the achievement of long-term, clinically relevant weight loss